Progression of Diabetic Retinopathy After Phacoemulsification in Diabetic Patients: a Three-year Analysis
Overview
Authors
Affiliations
Background: This retrospective study was conducted to analyze the progression rates of diabetic retinopathy (DR) after phacoemulsification in diabetic patients and to determine whether phacoemulsification causes the progression of DR.
Methods: The medical charts of diabetic patients who had undergone cataract surgery using phacoemulsification techniques during a 3-year period and had completed 3 years of follow-up were retrospectively reviewed. Data were collected to evaluate the visual outcomes and progression of DR postoperatively. The retinopathy progression rates of operated and nonoperated eyes were compared.
Results: Thirty-seven diabetic patients were enrolled. Binocular cataract surgeries were performed in 14 patients. Monocular cataract surgeries were performed in the remaining 23 patients whose nonoperated fellow eyes served as the control group. The postoperative retinopathy progression rates of eyes with preoperative mild to moderate nonproliferative diabetic retinopathy (NPDR) were significantly greater than eyes without preoperative retinopathy whether at postoperative 1 year or postoperative 3 years. No statistical significance was found for the rate of retinopathy progression between operated and nonoperated eyes at 1 year and 3 years postoperatively. Of 51 operated eyes, 33 (64.7%) achieved an uncorrected visual acuity of 20/40 at 1 year postoperatively, and 47 (92.1%) had improvement of visual acuity of more than two lines.
Conclusion: Uncomplicated phocoemulsificaton had no significant influence on the postoperative progression of DR. Patients with preoperative NPDR had greater chances to show postoperative retinopathy progression. The majority of diabetic patients who had no DR or had mild to moderate NPDR achieved visual improvement after phacoemulsification.
Sruthi R, Saikumar S, Gopalakrishnan M Oman J Ophthalmol. 2024; 17(1):72-77.
PMID: 38524349 PMC: 10957061. DOI: 10.4103/ojo.ojo_292_22.
Feng L, Azhati G, Li T, Liu F J Ophthalmol. 2021; 2021:6641944.
PMID: 33854796 PMC: 8019390. DOI: 10.1155/2021/6641944.
Cataract in diabetes mellitus.
Kiziltoprak H, Tekin K, Inanc M, Goker Y World J Diabetes. 2019; 10(3):140-153.
PMID: 30891150 PMC: 6422859. DOI: 10.4239/wjd.v10.i3.140.
Cataract surgery in diabetes mellitus: A systematic review.
Kelkar A, Kelkar J, Mehta H, Amoaku W Indian J Ophthalmol. 2018; 66(10):1401-1410.
PMID: 30249823 PMC: 6173035. DOI: 10.4103/ijo.IJO_1158_17.
Liu J, Jones R, Zhao J, Zhang J, Zhang F PLoS One. 2015; 10(5):e0126343.
PMID: 25965404 PMC: 4428827. DOI: 10.1371/journal.pone.0126343.